Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Fungal Blepharitis With Natacyn
NCT07856680Phase 4Not yet recruiting
- Start
- Oct 2026
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of natamycin in Fungal blepharitis. Primary endpoints: Visual Analog Scale for Irritation at 21 days, Visual Analog Scale for Itching at 21 days and 1 more. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
natamycin
03
Conditions
Fungal blepharitis
Beyond the preview
Go deeper on NCT07856680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07856680.